Healthcare provider profile · identity verified

Jay Howard Hansen, MD

Family Practice · ST GEORGE, UT · NPI 1710084363

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	623	171
Levothyroxine Sodium	Levothyroxine Sodium	362	103
Lisinopril	Lisinopril	331	104
Rosuvastatin Calcium	Rosuvastatin Calcium	312	95
Omeprazole	Omeprazole	288	90
Amlodipine Besylate	Amlodipine Besylate	240	72
Tamsulosin Hcl	Tamsulosin Hcl	221	67
Losartan Potassium	Losartan Potassium	190	61
Gabapentin	Gabapentin	181	58
Trazodone Hcl	Trazodone Hcl	172	50
Metformin Hcl	Metformin Hcl	168	52
Pantoprazole Sodium	Pantoprazole Sodium	160	49
Metoprolol Succinate	Metoprolol Succinate	146	46
Sertraline Hcl	Sertraline Hcl	128	35
Zolpidem Tartrate	Zolpidem Tartrate	109	27
Alendronate Sodium	Alendronate Sodium	104	33
Simvastatin	Simvastatin	103	28
Hydrochlorothiazide	Hydrochlorothiazide	95	30
Pravastatin Sodium	Pravastatin Sodium	89	28
Duloxetine Hcl	Duloxetine Hcl	87	26
Tramadol Hcl	Tramadol Hcl	84	29
Ozempic	Semaglutide	83	13
Metformin Hcl Er	Metformin Hcl	81	29
Escitalopram Oxalate	Escitalopram Oxalate	80	24
Meloxicam	Meloxicam	76	34
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	70	22
Montelukast Sodium	Montelukast Sodium	70	24
Furosemide	Furosemide	67	22
Bupropion Xl	Bupropion Hcl	64	20
Eliquis	Apixaban	63	17
Fluticasone Propionate	Fluticasone Propionate	63	23
Baclofen	Baclofen	60	13
Estradiol	Estradiol	58	18
Albuterol Sulfate Hfa	Albuterol Sulfate	56	36
Potassium Chloride	Potassium Chloride	50	17
Alprazolam	Alprazolam	49	16
Allopurinol	Allopurinol	48	16
Topiramate	Topiramate	48	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	47	16
Finasteride	Finasteride	46	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	14
Metoprolol Tartrate	Metoprolol Tartrate	43	13
Prednisone	Prednisone	43	40
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	42	14
Quetiapine Fumarate	Quetiapine Fumarate	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	26
Synthroid	Levothyroxine Sodium	37	suppressed
Propranolol Hcl	Propranolol Hcl	36	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	25
Clopidogrel	Clopidogrel Bisulfate	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Tizanidine Hcl	Tizanidine Hcl	33	18
Pregabalin	Pregabalin	31	suppressed
Glipizide	Glipizide	30	suppressed
Benazepril Hcl	Benazepril Hcl	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	12
Ibuprofen	Ibuprofen	29	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	28	27
Ezetimibe	Ezetimibe	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Valacyclovir	Valacyclovir Hcl	26	15
Valsartan	Valsartan	26	suppressed
Atenolol	Atenolol	25	suppressed
Carvedilol	Carvedilol	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Amoxicillin	Amoxicillin	24	21
Mirtazapine	Mirtazapine	24	suppressed
Celecoxib	Celecoxib	23	11
Donepezil Hcl	Donepezil Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Famotidine	Famotidine	21	suppressed
Fluconazole	Fluconazole	21	11
Memantine Hcl	Memantine Hcl	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Cephalexin	Cephalexin	19	17
Januvia	Sitagliptin Phosphate	18	suppressed
Liothyronine Sodium	Liothyronine Sodium	18	suppressed
Naproxen	Naproxen	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lorazepam	Lorazepam	16	12
Triamcinolone Acetonide	Triamcinolone Acetonide	16	12
Glimepiride	Glimepiride	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Nystatin	Nystatin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Ramipril	Ramipril	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Insulin Lispro	Insulin Lispro	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error